Drug Enforcement D-310-2013

Subpotent Drug: Product did not conform to the 18-month stability test specification for active Free Benzocaine.

Status

Terminated

Classification

Class III

Report Date

May 8, 2013

Termination Date

August 14, 2014

Product Information

Product description
Cherry Cepacol Sore Throat Lozenges, Benzocaine 15 mg | Menthol 3.6 mg, a)16-count, NDC 63824-711-16 b) Institutional Size, 576-count, NDC 63824-711-98, OTC, Dist. by: Reckitt Benckiser, Parsippany, NJ 07054
Product quantity
27,718 cases 16 count and 7,551 cases 576 count
Reason for recall
Subpotent Drug: Product did not conform to the 18-month stability test specification for active Free Benzocaine.
Recall initiation reason
Initial firm notification
Letter
Distribution pattern
Nationwide

Location & Firm

Recalling firm
Reckitt Benckiser Inc
Address
399 Interpace Parkway

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-310-2013
Event ID
64652
Recall initiation date
March 18, 2013
Center classification date
May 1, 2013
Code info
16 count: AG156 Exp 11/13, AG257 Exp 12/13, AH388 02/14, AJ167 03/14, AL367 Exp 05/14, AL555 & AL568 Exp 06/14, AM141 Exp 07/14. 576 Count: AK505 Exp 04/14, AK570 Exp 05/14, AH368 & AH398 Exp 02/14, AJ000 Exp 03/14, AG596 Exp 12/13,
More code info